<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03489603</url>
  </required_header>
  <id_info>
    <org_study_id>TROCAR 2017</org_study_id>
    <nct_id>NCT03489603</nct_id>
  </id_info>
  <brief_title>Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation Myocardial Infarction in Patients With Chest Pain in Emergency Departments in Italy-An Observational Study</brief_title>
  <official_title>Valutazione Clinica e Farmacoeconomica Delle Metodiche di Dosaggio Per la TROponina CARdiaca Per la Diagnosi di NSTEMI Nel Setting Della Pratica Clinica Della Medicina di Pronto Soccorso Nel Territorio Nazionale</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marco Marchetti</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Ospedaliero Universitaria Maggiore della Carita</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Sanitaria Locale ASL 6, Livorno</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Spedali Civili di Brescia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Civile - Padova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>S. Andrea Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Policlinico Umberto I</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Carlo Public Hospital, Potenza, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero-Universitaria Consorziale</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Policlinico Universitario, Catania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Sant'Anna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale di Cattinara - Azienda Universitaria Integrata -Trieste</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abbott s.r.l.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>InformaPRO s.r.l.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Istituto Superiore di Sanità</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myocardial infarction is one of the leading causes of death and disability worldwide. In
      addition to standard diagnostic methods, it has been shown that high-sensitivity cardiac
      troponin assays allow greater sensitivity in the diagnosis of myocardial infarction and
      assume a central role for both exclusion (&quot;rule out&quot;) and confirmation (&quot;rule in&quot;) of acute
      myocardial infarction , while allowing to reduce the time interval between ER admission and
      presumptive diagnosis.

      Considering the relevance of this topic, we propose to conduct an observational study in real
      world clinical practice settings at Emergency Departments, aiming to evaluate clinical and
      economic aspects deriving from the use of the different quantitative assays of
      high-sensitivity cardiac troponin currently available in patients with suspected acute
      myocardial infarction and non-ST-elevation ECG (NSTEMI) on the admission, including time of
      diagnosis and number of laboratory and imaging tests performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Observational, prospective, real-world clinical practice, multicentric study, conducted at 12
      Emergency Departments in Italy.

      Patients with suspected non-ST-elevation myocardial infarction (NSTEMI) who have undergone at
      least one high-sensitivity cardiac troponin test will be included.

      Patients will be enrolled in the study after verification of selection criteria.

      Enrollment is consecutive; each Center will suspend enrollment when it has reached the
      expected number of patients.

      An electronic data collection form (eCRF) will be used to automatically generate an
      enrollment number to identify each patient.

      Given the observational nature of the study, high-sensitivity cardiac troponin assays will be
      used according to current clinical practice.

      Patients will be examined in the ED, and on a 30-day follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 18, 2018</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time to diagnosis in the emergency department</measure>
    <time_frame>1-3-6 hours</time_frame>
    <description>Time from admission at the emergency department and diagnosis or exclusion of NSTEMI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of ruled-in and ruled-out patients</measure>
    <time_frame>1-3-6 hours</time_frame>
    <description>Number of patients diagnosed with NSTEMI and hospitalized, and number of patients discharged from the emergency room after exclusion of NSTEMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of tests performed</measure>
    <time_frame>1-3-6 hours</time_frame>
    <description>Number of high-sensitivity cardiac troponin tests performed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients diagnosed with a Major Adverse Clinical Event</measure>
    <time_frame>30 days after the first assessment</time_frame>
    <description>number of patients with myocardial infarction, stroke, or unplanned revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day mortality</measure>
    <time_frame>30 days following admission</time_frame>
    <description>Death rate 30 days after admission to the emergency department</description>
  </secondary_outcome>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>NSTEMI - Non-ST Segment Elevation MI</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients attending the Emergency Department with chest pain
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with chest pain

          -  Performing at least one cardiac troponin determination test

          -  Written informed consent

        Exclusion Criteria:

          -  Refusal to provide informed consent

          -  Elevation of the ST segment to the ECG

          -  Pregnancy or breastfeeding

          -  Any other clinical condition not judged by the investigator compatible with
             participation in the present study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Marchetti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto Superiore di Sanità</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marco Marchetti, MD</last_name>
    <phone>49906710</phone>
    <phone_ext>06</phone_ext>
    <email>marco.marchetti@iss.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laura Camoni, MD</last_name>
    <phone>49904131</phone>
    <phone_ext>06</phone_ext>
    <email>laura.camoni@iss.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istituto Superiore di Sanità</name>
      <address>
        <city>Roma</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Marchetti</last_name>
      <phone>49906710</phone>
      <phone_ext>06</phone_ext>
      <email>marco.marchetti@iss.it</email>
    </contact>
    <contact_backup>
      <last_name>Laura Camoni</last_name>
      <phone>49904131</phone>
      <phone_ext>06</phone_ext>
      <email>laura.camoni@iss.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons, Thygesen K, Alpert JS, White HD; Biomarker Subcommittee, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA; ECG Subcommittee, Chaitman BR, Clemmensen PM, Johanson P, Hod H; Imaging Subcommittee, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ; Classification Subcommittee, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW; Intervention Subcommittee, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J; Trials &amp; Registries Subcommittee, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML; Trials &amp; Registries Subcommittee, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G; Trials &amp; Registries Subcommittee, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D; Trials &amp; Registries Subcommittee, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98. doi: 10.1016/j.jacc.2012.08.001. Epub 2012 Sep 5.</citation>
    <PMID>22958960</PMID>
  </reference>
  <reference>
    <citation>Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S. [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome). 2016 Oct;17(10):831-872. doi: 10.1714/2464.25804. Italian.</citation>
    <PMID>27869901</PMID>
  </reference>
  <reference>
    <citation>Apple FS, Collinson PO; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2012 Jan;58(1):54-61. doi: 10.1373/clinchem.2011.165795. Epub 2011 Sep 30. Review. Erratum in: Clin Chem. 2012 Apr;58(4):796.</citation>
    <PMID>21965555</PMID>
  </reference>
  <reference>
    <citation>Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012 Nov;58(11):1574-81. doi: 10.1373/clinchem.2012.192716. Epub 2012 Sep 14.</citation>
    <PMID>22983113</PMID>
  </reference>
  <reference>
    <citation>Shah AS, Anand A, Sandoval Y, Lee KK, Smith SW, Adamson PD, Chapman AR, Langdon T, Sandeman D, Vaswani A, Strachan FE, Ferry A, Stirzaker AG, Reid A, Gray AJ, Collinson PO, McAllister DA, Apple FS, Newby DE, Mills NL; High-STEACS investigators. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet. 2015 Dec 19;386(10012):2481-8. doi: 10.1016/S0140-6736(15)00391-8. Epub 2015 Oct 8.</citation>
    <PMID>26454362</PMID>
  </reference>
  <reference>
    <citation>Rubini Gimenez M, Twerenbold R, Jaeger C, Schindler C, Puelacher C, Wildi K, Reichlin T, Haaf P, Merk S, Honegger U, Wagener M, Druey S, Schumacher C, Krivoshei L, Hillinger P, Herrmann T, Campodarve I, Rentsch K, Bassetti S, Osswald S, Mueller C. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med. 2015 Aug;128(8):861-870.e4. doi: 10.1016/j.amjmed.2015.01.046. Epub 2015 Mar 31.</citation>
    <PMID>25840034</PMID>
  </reference>
  <reference>
    <citation>Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, Cruikshank A, Reid A, Stoddart M, Strachan F, Walker S, Collinson PO, Apple FS, Gray AJ, Fox KA, Newby DE, Mills NL. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ. 2015 Jan 21;350:g7873. doi: 10.1136/bmj.g7873. Erratum in: BMJ. 2015;350:h626. BMJ. 2016 Sep 06;354:i4840.</citation>
    <PMID>25609052</PMID>
  </reference>
  <reference>
    <citation>Casagranda I, Cavazza M, Clerico A, Galvani M, Ottani F, Zaninotto M, Biasucci LM, Cervellin G, Lenzi T, Lippi G, Plebani M, Tubaro M. Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation. Clin Chem Lab Med. 2013 Sep;51(9):1727-37. doi: 10.1515/cclm-2013-0423.</citation>
    <PMID>23893689</PMID>
  </reference>
  <reference>
    <citation>Cremonesi P, Di Bella E, Montefiori M. Cost analysis of emergency department. J Prev Med Hyg. 2010 Dec;51(4):157-63.</citation>
    <PMID>21553561</PMID>
  </reference>
  <reference>
    <citation>Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, Wild P, Genth-Zotz S, Warnholtz A, Giannitsis E, Möckel M, Bickel C, Peetz D, Lackner K, Baldus S, Münzel T, Blankenberg S. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA. 2011 Dec 28;306(24):2684-93. doi: 10.1001/jama.2011.1896.</citation>
    <PMID>22203537</PMID>
  </reference>
  <reference>
    <citation>Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, Bassetti S, Steuer S, Winkler K, Peter F, Meissner J, Haaf P, Potocki M, Drexler B, Osswald S, Mueller C. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2011 Jul 12;124(2):136-45. doi: 10.1161/CIRCULATIONAHA.111.023937. Epub 2011 Jun 27.</citation>
    <PMID>21709058</PMID>
  </reference>
  <reference>
    <citation>Pickering JW, Greenslade JH, Cullen L, Flaws D, Parsonage W, George P, Worster A, Kavsak PA, Than MP. Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction. Heart. 2016 Aug 15;102(16):1270-8. doi: 10.1136/heartjnl-2015-308505. Epub 2016 Mar 8.</citation>
    <PMID>26955848</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2018</study_first_submitted>
  <study_first_submitted_qc>April 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2018</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Istituto Superiore di Sanità</investigator_affiliation>
    <investigator_full_name>Marco Marchetti</investigator_full_name>
    <investigator_title>Director of the National Health Technology Assessment Centre</investigator_title>
  </responsible_party>
  <keyword>Troponin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Non-ST Elevated Myocardial Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

